321 related articles for article (PubMed ID: 23533228)
1. Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes.
Costa-Barbosa FA; Balasubramanian R; Keefe KW; Shaw ND; Al-Tassan N; Plummer L; Dwyer AA; Buck CL; Choi JH; Seminara SB; Quinton R; Monies D; Meyer B; Hall JE; Pitteloud N; Crowley WF
J Clin Endocrinol Metab; 2013 May; 98(5):E943-53. PubMed ID: 23533228
[TBL] [Abstract][Full Text] [Related]
2. Kallmann syndrome in women: from genes to diagnosis and treatment.
Meczekalski B; Podfigurna-Stopa A; Smolarczyk R; Katulski K; Genazzani AR
Gynecol Endocrinol; 2013 Apr; 29(4):296-300. PubMed ID: 23368665
[TBL] [Abstract][Full Text] [Related]
3. Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland.
Laitinen EM; Vaaralahti K; Tommiska J; Eklund E; Tervaniemi M; Valanne L; Raivio T
Orphanet J Rare Dis; 2011 Jun; 6():41. PubMed ID: 21682876
[TBL] [Abstract][Full Text] [Related]
4. Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia.
Raivio T; Avbelj M; McCabe MJ; Romero CJ; Dwyer AA; Tommiska J; Sykiotis GP; Gregory LC; Diaczok D; Tziaferi V; Elting MW; Padidela R; Plummer L; Martin C; Feng B; Zhang C; Zhou QY; Chen H; Mohammadi M; Quinton R; Sidis Y; Radovick S; Dattani MT; Pitteloud N
J Clin Endocrinol Metab; 2012 Apr; 97(4):E694-9. PubMed ID: 22319038
[TBL] [Abstract][Full Text] [Related]
5. Novel FGFR1 and KISS1R Mutations in Chinese Kallmann Syndrome Males with Cleft Lip/Palate.
Xu H; Niu Y; Wang T; Liu S; Xu H; Wang S; Liu J; Ye Z
Biomed Res Int; 2015; 2015():649698. PubMed ID: 26199944
[TBL] [Abstract][Full Text] [Related]
6. Kallmann's syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations.
Salenave S; Chanson P; Bry H; Pugeat M; Cabrol S; Carel JC; Murat A; Lecomte P; Brailly S; Hardelin JP; Dodé C; Young J
J Clin Endocrinol Metab; 2008 Mar; 93(3):758-63. PubMed ID: 18160472
[TBL] [Abstract][Full Text] [Related]
7. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.
Sato N; Katsumata N; Kagami M; Hasegawa T; Hori N; Kawakita S; Minowada S; Shimotsuka A; Shishiba Y; Yokozawa M; Yasuda T; Nagasaki K; Hasegawa D; Hasegawa Y; Tachibana K; Naiki Y; Horikawa R; Tanaka T; Ogata T
J Clin Endocrinol Metab; 2004 Mar; 89(3):1079-88. PubMed ID: 15001591
[TBL] [Abstract][Full Text] [Related]
8. Clinical genetics of Kallmann syndrome.
Dodé C; Hardelin JP
Ann Endocrinol (Paris); 2010 May; 71(3):149-57. PubMed ID: 20362962
[TBL] [Abstract][Full Text] [Related]
9. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes.
Pitteloud N; Meysing A; Quinton R; Acierno JS; Dwyer AA; Plummer L; Fliers E; Boepple P; Hayes F; Seminara S; Hughes VA; Ma J; Bouloux P; Mohammadi M; Crowley WF
Mol Cell Endocrinol; 2006 Jul; 254-255():60-9. PubMed ID: 16764984
[TBL] [Abstract][Full Text] [Related]
10. Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations.
Laitinen EM; Tommiska J; Sane T; Vaaralahti K; Toppari J; Raivio T
PLoS One; 2012; 7(6):e39450. PubMed ID: 22724017
[TBL] [Abstract][Full Text] [Related]
11. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
Hardelin JP; Dodé C
Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492
[TBL] [Abstract][Full Text] [Related]
12. Clinical genetic testing for Kallmann syndrome.
Layman LC
J Clin Endocrinol Metab; 2013 May; 98(5):1860-2. PubMed ID: 23650337
[No Abstract] [Full Text] [Related]
13. Greater prevalence of PROKR2 mutations in Kallmann syndrome patients from the Maghreb than in European patients.
Sarfati J; Fouveaut C; Leroy C; Jeanpierre M; Hardelin JP; Dodé C
Eur J Endocrinol; 2013 Dec; 169(6):805-9. PubMed ID: 24031091
[TBL] [Abstract][Full Text] [Related]
14. Kallmann syndrome with FGFR1 and KAL1 mutations detected during fetal life.
Sarfati J; Bouvattier C; Bry-Gauillard H; Cartes A; Bouligand J; Young J
Orphanet J Rare Dis; 2015 Jun; 10():71. PubMed ID: 26051373
[TBL] [Abstract][Full Text] [Related]
15. The results of CHD7 analysis in clinically well-characterized patients with Kallmann syndrome.
Bergman JE; de Ronde W; Jongmans MC; Wolffenbuttel BH; Drop SL; Hermus A; Bocca G; Hoefsloot LH; van Ravenswaaij-Arts CM
J Clin Endocrinol Metab; 2012 May; 97(5):E858-62. PubMed ID: 22399515
[TBL] [Abstract][Full Text] [Related]
16. Dental agenesis in Kallmann syndrome individuals with FGFR1 mutations.
Bailleul-Forestier I; Gros C; Zenaty D; Bennaceur S; Leger J; de Roux N
Int J Paediatr Dent; 2010 Jul; 20(4):305-12. PubMed ID: 20536592
[TBL] [Abstract][Full Text] [Related]
17. [Hypogonadotropic hypogonadism: new aspects in the regulation of hypothalamic-pituitary-gonadal axis].
Brioude F; Bouvattier CE; Lombès M
Ann Endocrinol (Paris); 2010 Sep; 71 Suppl 1():S33-41. PubMed ID: 21237329
[TBL] [Abstract][Full Text] [Related]
18. Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome.
Kim SH; Hu Y; Cadman S; Bouloux P
J Neuroendocrinol; 2008 Feb; 20(2):141-63. PubMed ID: 18034870
[TBL] [Abstract][Full Text] [Related]
19. [Children with idiopathic hypogonadotropic hypogonadism: clinical data analysis and mutations analysis of KAL1 and FGFR1 gene].
Qin M; Gong C; Qi Z; Wu D; Liu M; Gu Y; Cao B; Li W; Liang X
Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):942-7. PubMed ID: 25619354
[TBL] [Abstract][Full Text] [Related]
20. Clinical assessment and molecular analysis of GnRHR and KAL1 genes in males with idiopathic hypogonadotrophic hypogonadism.
Versiani BR; Trarbach E; Koenigkam-Santos M; Dos Santos AC; Elias LL; Moreira AC; Latronico AC; de Castro M
Clin Endocrinol (Oxf); 2007 Feb; 66(2):173-9. PubMed ID: 17223984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
